NDC 0310-3200
ANDEXXA
Andexanet Alfa
ANDEXXA is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Andexanet Alfa.
| Product ID | 0310-3200_2d9d90a6-63e6-46ef-96ff-dd6519ae7b6c |
| NDC | 0310-3200 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ANDEXXA |
| Generic Name | Andexanet Alfa |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-07-12 |
| Marketing Category | BLA / |
| Application Number | BLA125586 |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | ANDEXANET ALFA |
| Active Ingredient Strength | 200 mg/20mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
Packaging
NDC 0310-3200-04
4 VIAL, SINGLE-USE in 1 CARTON (0310-3200-04) > 20 mL in 1 VIAL, SINGLE-USE (0310-3200-01)
| Marketing Start Date | 2022-07-12 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
NDC Crossover Matching brand name "ANDEXXA" or generic name "Andexanet Alfa"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0310-3200 | ANDEXXA | andexanet alfa |
| 69853-0101 | ANDEXXA | andexanet alfa |
| 69853-0102 | ANDEXXA | andexanet alfa |
Trademark Results [ANDEXXA]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ANDEXXA 86776730 5251742 Live/Registered |
Portola Pharmaceuticals, Inc. 2015-10-02 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.